Search Results for

Showing 1 - 10 of 55 results
  1. Telling the story of OCT

    Telling the story of OCT Optical coherence tomography (OCT) is a technology invented by ARVO members that helps preserve patients' sight, saves taxpayers billions of dollars and enables further discoveries in science and medicine. See how ARVO has shared the impact of OCT with vision scientists, patients, and policymakers.  OCT projects

  2. OCT paper press release

    Embargoed until Dec. 7, 12pm EDT Media contact: Marisa Lavine   +1.240.221.2923   mlavine@arvo.org                                                                                                                                                                                                                                New study finds federally-funded technology saved Medicare $9 billion Rockville, Md. — A new study quantifying a 21-fold return on investment suggests an e

  3. AMPC Candidates

    All candidate bios and nomination statements are available on the official ballots

  4. Professional Development and Education Committee

    Professional Development and Education Committee Professional Development and Education Committee Description The Professional Development and Education Committee (PDEC) provides oversight and evaluation of ARVO's educational and training activities, including ARVO-sponsored/cosponsored and conferences, courses, symposia, workshops, tutorials, etc. and online education such as webinars, podcasts, courses, etc. Activities Provides oversight for ARVO's portfolio of education and training pr

  5. Board of Trustees

    Board of Trustees The Board of Trustees is comprised of elected members from ARVO's 13 Scientific Sections along with elected and trustee-appointed officers. The president and vice president(s) are elected from within the Board each year. The executive vice president is elected by the general membership to a five-year term and is a voting member of the Board of Trustees. The ARVO executive director serves as an ex officio member of the Board. For more information on Board of Trustee duties,

  6. Spotlight on members: Spark

    Spotlight on members From hospital funding to FDA approval Spark Therapeutics develops gene therapy for inherited retinal blindness After over two decades of research and development in gene therapy, Katherine A. High, MD, co-founder, president and chief scientific officer of Spark Therapeutics, is breathing a big sigh of relief this fall. On Oct. 12, the Food and Drug Administration unanimously voted to approve voretigene neparvovec, Spark Therapeutics' gene therapy treatment for inherited b

  7. Organizers

    Organizers Conference Organizers Committee Members

  8. Journals and Publications landing

    Journals and Publications ARVO Journals           Publications Grant The ARVO Publications Grant is available to authors who need funding assistance to publish in one of our three journals: Investigative Ophthalmology & Visual Science  (IOVS); Journal of Vision (JOV); and Translational Vision Science & Technology (TVST). This grant is supported by the ARVO Foundation and aligns with ARVO’s goal to capture the full spectrum of vision science in our family of journals. Several indivi